Validation of the clinical treatment score post 5 years (CTS5) in women with hormone receptor positive, HER2-negative, node-negative disease from the TAILORx study
dc.contributor.author | Sestak, I | en_US |
dc.contributor.author | Crager, M | en_US |
dc.contributor.author | Cuzick, J | en_US |
dc.contributor.author | Dowsett, M | en_US |
dc.contributor.author | Shak, S | en_US |
dc.contributor.author | Tang, G | en_US |
dc.contributor.author | Gray, R | en_US |
dc.contributor.author | Sparano, J | en_US |
dc.date.accessioned | 2020-10-27T16:04:45Z | |
dc.date.available | 2019-09-13 | en_US |
dc.date.issued | 2020-02 | en_US |
dc.identifier.issn | 0008-5472 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/67813 | |
dc.title | Validation of the clinical treatment score post 5 years (CTS5) in women with hormone receptor positive, HER2-negative, node-negative disease from the TAILORx study | en_US |
dc.type | Conference Proceeding | |
dc.identifier.doi | 10.1158/1538-7445.SABCS19-GS4-03 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000527012500047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 4 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 80 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1181]